BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-7.84 Cr | ₹-1.21 Cr | ₹24 Cr | ₹-17 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-7.84 Cr |
| Mar2024 | ₹-1.21 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of BAL PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.84 Cr | Negative | |
| Mar2024 | ₹-1.21 Cr | Negative | |
| Mar2023 | ₹24 Cr | Positive | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-17 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹116.6 Cr | -1.6% | -8.6% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -1.6% |
-8.6% |
-40.2% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses